India to Mozambique: Tenofovir Export Trade Route

The India to Mozambique Tenofovir corridor is one of India's established pharmaceutical export routes, with 117 shipments documented worth a combined $81.7M USD. The route is dominated by STRIDES PHARMA SCIENCE LIMITED, which alone accounts for roughly 22% of all export value, reflecting the consolidated nature of India's tenofovir manufacturing sector.

Across 17 active suppliers, the average shipment value stands at $698.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with tenofovir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 27.1%, placing it at rank #1 among India's top tenofovir export destinations globally.

On the import side, key buyers of Indian tenofovir in Mozambique include MINISTERIO DA SAUDE, MINISTRY OF HEALTH, I SOLUTIONS POLANERBAAN 11 and 25 others. MINISTERIO DA SAUDE is the single largest importer with 4 shipments valued at $17.7M USD.

India's tenofovir exports to Mozambique are driven primarily by a handful of large-scale manufacturers. STRIDES PHARMA SCIENCE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Mozambique benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STRIDES PHARMA SCIENCE LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together account for 49% of total trade value on this route. The average shipment value of $698.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as dolutegravir + lamivudine + tenofovir disopr tablet and dolutegravir, lamivudine and tenofovir, suggesting that buyers in Mozambique tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MINISTERIO DA SAUDE is the largest importer with 4 shipments worth $17.7M USD — representing 22% of all tenofovir imports from India on this route. A total of 28 buyers are active on this corridor.